/People

Katherine High

Investor

Scientific Advisory Group Member at Pathway to Cures

Find your path to Katherine

Sign up to see every warm intro you have to Katherine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Katherine. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

High is a visiting professor at Rockefeller University and board member of Incyte, CRISPR Therapeutics, and Virion Therapeutics. She co-founded Spark Therapeutics and is a pioneer in AAV-mediated gene therapy for hemophilia.

Colleagues at Pathway to Cures

Frequently asked questions

Who is Katherine High?
High is a visiting professor at Rockefeller University and board member of Incyte, CRISPR Therapeutics, and Virion Therapeutics. She co-founded Spark Therapeutics and is a pioneer in AAV-mediated gene therapy for hemophilia.
Where does Katherine High work?
Katherine High is Scientific Advisory Group Member at Pathway to Cures.

About this profile. Compiled from public sources — Pathway to Cures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights